BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270 AND Prognosis
4 results:

  • 1. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
    Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
    Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Correlation of miR-181a and three HOXA genes as useful biomarkers in acute myeloid leukemia.
    Xu P; Zhou D; Yan G; Ouyang J; Chen B
    Int J Lab Hematol; 2020 Feb; 42(1):16-22. PubMed ID: 31670914
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
    Coenen EA; Zwaan CM; Reinhardt D; Harrison CJ; Haas OA; de Haas V; Mihál V; De Moerloose B; Jeison M; Rubnitz JE; Tomizawa D; Johnston D; Alonzo TA; Hasle H; Auvrignon A; Dworzak M; Pession A; van der Velden VH; Swansbury J; Wong KF; Terui K; Savasan S; Winstanley M; Vaitkeviciene G; Zimmermann M; Pieters R; van den Heuvel-Eibrink MM
    Blood; 2013 Oct; 122(15):2704-13. PubMed ID: 23974201
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML.
    Li Z; Huang H; Li Y; Jiang X; Chen P; Arnovitz S; Radmacher MD; Maharry K; Elkahloun A; Yang X; He C; He M; Zhang Z; Dohner K; Neilly MB; Price C; Lussier YA; Zhang Y; Larson RA; Le Beau MM; Caligiuri MA; Bullinger L; Valk PJ; Delwel R; Lowenberg B; Liu PP; Marcucci G; Bloomfield CD; Rowley JD; Chen J
    Blood; 2012 Mar; 119(10):2314-24. PubMed ID: 22251480
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.